An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
Top Gene Interactions
Auranofin Interacts with Diseases
|Disease||Inference Score||References/Inference Genes|
|Diabetes Mellitus, Experimental||30.39|
|Diabetes Mellitus, Type 2||22.13|
|Kidney Failure, Chronic||18.48|
|Alcoholic liver cirrhosis||18.39|